Patent details

1229909 Title: Transdermale toediening van lasofoxifeen.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
1229909
WO Application Number:
US0117567
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-payment of the annual fee
Application number:
19397512
WO Publication Number:
WO01091724
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
EP1229909;

Dates

Filing date:
31/05/2001
Grant date:
12/11/2003
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
12/11/2003
EP B1 Publication Date:
12/11/2003
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
12/02/2004
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/05/2021
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
01/12/2009

Applicant/holder

From:
12/11/2003
 
 

 

Name:
Watson Pharmaceuticals, Inc.
Address:
Corona, CA 92880, United States of America (US)

Domicile Holder

Name:
Mewburn Ellis & Co
From:
02/02/2004
Address:
Postbus 29720, 2502 LS Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
FIKSTAD, David
Address:
United States of America (US)

2

Name:
QUAN, Danyi
Address:
United States of America (US)

Priority

Priority Patent Number:
208789 P
Priority Date:
01/06/2000
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K31/40; A61K9/70; A61P5/30;

Publication

Bulletin

1

Bulletin Heading:
VE4
Journal edition number:
201002
Publication date:
01/02/2010
Description:
Vervallen Europese octrooien wegens niet betalen van een jaarcijns

2

Bulletin Heading:
PE2
Journal edition number:
200404
Publication date:
01/04/2004
Description:
Verleende Europese octrooien die hebben voldaan aan art. 29P (ROW 1910) of art. 52 (ROW 1995)

3

Bulletin Heading:
PE3
Journal edition number:
200404
Publication date:
01/04/2004
Description:
Verleende Europese octrooien uit PE2 in alfabetische volgorde van namen van octrooihouders

4

Bulletin Heading:
PE1
Journal edition number:
200401
Publication date:
05/01/2004
Description:
Verleende Europese octrooien in nummervolgorde

Terms/Procedural Changes

Description:
Termijn voor indienen vertaling Europees octrooi [EN]
Date:
12/02/2004

Correspondence

1

Sent On Date:
04/12/2009
Letter Type:
Vervalbrief [EN]
Reference:
To:
Watson Pharmaceuticals, Inc., P.O. Box 1900, Corona, California 91718-1900, United States of America (US)

2

Received On Date:
12/02/2004
Letter Type:
Vertaling Europees octrooi [EN]
Reference:
P213214EP/NL
From:
Dr. R. Jorritsma c.s., N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

3

Sent On Date:
02/02/2004
Letter Type:
Termijnbrief [EN]
Reference:
BULLETIN 0346
To:
Mewburn Ellis & Co, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

4

Received On Date:
23/01/2004
Letter Type:
Voorlopige domiciliekeuze [EN]
Reference:
5982541.EPG
From:
Mewburn Ellis & Co, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

5

Sent On Date:
12/11/2003
Letter Type:
Termijnbrief [EN]
Reference:
BULLETIN 0346
To:
-

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
24/05/2008
Last Annual Fee Paid Number:
4
Payer:
Computer Packages Inc.
Filing date Document type Document Description Number of pages File Type